Scrutiny over insulin pricing intensifies in Washington

Congressional scrutiny over insulin prices is intensifying as Senate Finance Committee Chairman Chuck Grassley (R-Iowa) and Ranking Member Ron Wyden (D-Ore.) asked three PBMs to explain their role in